Immunology Drug Market Size, Share, and Growth Forecast, 2025 - 2032

Immunology Drug Market by Drug Class (Monoclonal Antibody, Immunosuppressants, Fusion Proteins, Others), Disease Indication (Rheumatoid Arthritis, Psoriatic Arthritis, Plaque Psoriasis, Ankylosing Spondylitis, Inflammatory Bowel Disease, Prophylaxis of Organ Rejection, Others), and Distribution Channel for Regional Analysis, 2025 - 2032

ID: PMRREP15259| 178 Pages | 1 Oct 2025 | Format: PDF, Excel, PPT* | Healthcare

Market Growth and Regional Outlook Report by Persistence Market Research

Table of Content

  1. Executive Summary
    1. Global Immunology Drug Market Snapshot, 2025 and 2032
    2. Market Opportunity Assessment, 2025 - 2032, US$ Bn
    3. Key Market Trends
    4. Future Market Projections
    5. Premium Market Insights
    6. Industry Developments and Key Market Events
    7. PMR Analysis and Recommendations
  2. Market Overview
    1. Market Scope and Definition
    2. Market Dynamics
      1. Drivers
      2. Restraints
      3. Opportunity
      4. Challenges
      5. Key Trends
    3. COVID-19 Impact Analysis
    4. Forecast Factors - Relevance and Impact
  3. Value Added Insights
    1. Value Chain Analysis
    2. Key Market Players
    3. Regulatory Landscape
    4. PESTLE Analysis
    5. Porter’s Five Forces Analysis
    6. Consumer Behavior Analysis
  4. Price Trend Analysis, 2019 - 2032
    1. Key Factors Impacting Disease Indication Prices
    2. Pricing Analysis, By Disease Indication
    3. Regional Prices and Disease Indication Preferences
  5. Global Immunology Drug Market Outlook
    1. Market Size (US$ Bn) Analysis and Forecast
      1. Historical Market Size (US$ Bn) Analysis, 2019-2024
      2. Market Size (US$ Bn) Analysis and Forecast, 2025-2032
    2. Global Immunology Drug Market Outlook: By Disease Indication
      1. Historical Market Size (US$ Bn) Analysis, By Disease Indication, 2019-2024
      2. Market Size (US$ Bn) Analysis and Forecast, By Disease Indication, 2025-2032
        1. Monoclonal Antibody
        2. Immunosuppressants
        3. Fusion Proteins
        4. Others
      3. Market Attractiveness Analysis: Disease Indication
    3. Global Immunology Drug Market Outlook: Application
      1. Historical Market Size (US$ Bn) Analysis, By Application, 2019-2024
      2. Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
        1. Rheumatoid Arthritis
        2. Psoriatic Arthritis
        3. Plaque Arthritis
        4. Ankylosing Spondylitis
        5. Inflammatory Bowel Disease
        6. Prophylaxis of Organ Rejection
        7. Others
      3. Market Attractiveness Analysis: Application
    4. Global Immunology Drug Market Outlook: Distribution Channel
      1. Historical Market Size (US$ Bn) Analysis, By Distribution Channel, 2019-2024
      2. Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2025-2032
        1. Hospital Pharmacies
        2. Retail Pharmacies
        3. Online Pharmacies
      3. Market Attractiveness Analysis: Distribution Channel
  6. Global Immunology Drug Market Outlook: Region
    1. Historical Market Size (US$ Bn) Analysis, By Region, 2019-2024
    2. Market Size (US$ Bn) Analysis and Forecast, By Region, 2025-2032
      1. North America
      2. Latin America
      3. Europe
      4. East Asia
      5. South Asia and Oceania
      6. Middle East & Africa
    3. Market Attractiveness Analysis: Region
  7. North America Immunology Drug Market Outlook
    1. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
      1. By Country
      2. By Disease Indication
      3. By Application
      4. By Distribution Channel
    2. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
      1. U.S.
      2. Canada
    3. Market Size (US$ Bn) Analysis and Forecast, By Disease Indication, 2025-2032
      1. Monoclonal Antibody
      2. Immunosuppressants
      3. Fusion Proteins
      4. Others
    4. Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
      1. Rheumatoid Arthritis
      2. Psoriatic Arthritis
      3. Plaque Arthritis
      4. Ankylosing Spondylitis
      5. Inflammatory Bowel Disease
      6. Prophylaxis of Organ Rejection
      7. Others
    5. Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2025-2032
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
    6. Market Attractiveness Analysis
  8. Europe Immunology Drug Market Outlook
    1. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
      1. By Country
      2. By Disease Indication
      3. By Application
      4. By Distribution Channel
    2. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
      1. Germany
      2. France
      3. U.K.
      4. Italy
      5. Spain
      6. Russia
      7. Rest of Europe
    3. Market Size (US$ Bn) Analysis and Forecast, By Disease Indication, 2025-2032
      1. Monoclonal Antibody
      2. Immunosuppressants
      3. Fusion Proteins Others
    4. Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
      1. Rheumatoid Arthritis
      2. Psoriatic Arthritis
      3. Plaque Arthritis
      4. Ankylosing Spondylitis
      5. Inflammatory Bowel Disease
      6. Prophylaxis of Organ Rejection
      7. Others
    5. Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2025-2032
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
    6. Market Attractiveness Analysis
  9. East Asia Immunology Drug Market Outlook
    1. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
      1. By Country
      2. By Disease Indication
      3. By Application
      4. By Distribution Channel
    2. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
      1. China
      2. Japan
      3. South Korea
    3. Market Size (US$ Bn) Analysis and Forecast, By Disease Indication, 2025-2032
      1. Monoclonal Antibody
      2. Immunosuppressants
      3. Fusion Proteins
      4. Others
    4. Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
      1. Rheumatoid Arthritis
      2. Psoriatic Arthritis
      3. Plaque Arthritis
      4. Ankylosing Spondylitis
      5. Inflammatory Bowel Disease
      6. Prophylaxis of Organ Rejection
      7. Others
    5. Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2025-2032
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
    6. Market Attractiveness Analysis
  10. South Asia & Oceania Immunology Drug Market Outlook
    1. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
      1. By Country
      2. By Disease Indication
      3. By Application
      4. By Distribution Channel
    2. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
      1. India
      2. Indonesia
      3. Thailand
      4. Singapore
      5. ANZ
      6. Rest of South Asia & Oceania
    3. Market Size (US$ Bn) Analysis and Forecast, By Disease Indication, 2025-2032
      1. Monoclonal Antibody
      2. Immunosuppressants
      3. Fusion Proteins
      4. Others
    4. Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
      1. Rheumatoid Arthritis
      2. Psoriatic Arthritis
      3. Plaque Arthritis
      4. Ankylosing Spondylitis
      5. Inflammatory Bowel Disease
      6. Prophylaxis of Organ Rejection
      7. Others
    5. Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2025-2032
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
      4. Others
    6. Market Attractiveness Analysis
  11. Latin America Immunology Drug Market Outlook
    1. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
      1. By Country
      2. By Disease Indication
      3. By Application
      4. By Distribution Channel
    2. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
      1. Brazil
      2. Mexico
      3. Rest of Latin America
    3. Market Size (US$ Bn) Analysis and Forecast, By Disease Indication, 2025-2032
      1. Monoclonal Antibody
      2. Immunosuppressants
      3. Fusion Proteins
      4. Others
    4. Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
      1. Rheumatoid Arthritis
      2. Psoriatic Arthritis
      3. Plaque Arthritis
      4. Ankylosing Spondylitis
      5. Inflammatory Bowel Disease
      6. Prophylaxis of Organ Rejection
      7. Others
    5. Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2025-2032
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
    6. Market Attractiveness Analysis
  12. Middle East & Africa Immunology Drug Market Outlook
    1. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
      1. By Country
      2. By Disease Indication
      3. By Application
      4. By Distribution Channel
    2. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
      1. GCC Countries
      2. Egypt
      3. South Africa
      4. Northern Africa
      5. Rest of Middle East & Africa
    3. Market Size (US$ Bn) Analysis and Forecast, By Disease Indication, 2025-2032
      1. Monoclonal Antibody
      2. Immunosuppressants
      3. Fusion Proteins
      4. Others
    4. Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
      1. Rheumatoid Arthritis
      2. Psoriatic Arthritis
      3. Plaque Arthritis
      4. Ankylosing Spondylitis
      5. Inflammatory Bowel Disease
      6. Prophylaxis of Organ Rejection
      7. Others
    5. Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2025-2032
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
    6. Market Attractiveness Analysis
  13. Competition Landscape
    1. Market Share Analysis, 2024
    2. Market Structure
      1. Competition Intensity Mapping By Market
      2. Competition Dashboard
    3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
      1. AbbVie, Inc.
        1. Overview
        2. Segments and Type
        3. Key Financials
        4. Market Developments
        5. Market Strategy
      2. Janssen Global Services, LLC
      3. Eli Lilly and Company
      4. Novartis AG
      5. Pfizer Inc.
      6. Bristol-Myers Squibb Company
      7. Merck Sharp & Dohme Corp.
      8. F. Hoffmann-La Roche Ltd.
      9. Amgen Inc.
      10. Astellas Pharma Inc.
      11. UCB SA
      12. Others
  14. Appendix
    1. Research Methodology
    2. Research Assumptions
    3. Acronyms and Abbreviations
We use cookies to improve user experience.
Google translate